An Australian stem cell and regenerative medicine company

July 24, 2020

Interview with Ross Macdonald and Kilian Kelly

William Canty of Boardroom.Media speaks with Dr Ross Macdonald and Dr Kilian Kelly about Cynata's market position, research and clinical trials.

June 23, 2020

“Cynata’s stem cell therapy could be a game changer for COVID-19 patients”

Listen to Stockhead’s resident Health and Biotech expert Tim Boreham discuss Cynata with CEO Dr Ross Macdonald

Here is the interview

April 07, 2020

Growing interest in stem cells for COVID-19 ailments

Read an article published in BioProcess International which explores Cynata’s interest in this area.

Read Story

April 03, 2020

Cynata Therapeutics (ASX:CYP) 1H20 results & outlook

Finance News Network discusses with Cynata CEO Dr Ross Macdonald the Company’s 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the company's Cymerus cell therapy platform

Read More

January 31, 2020

Feature article in “Clinical Leader” on Cynata’s osteoarthritis program: “Stem Cell Therapy Trial Offers Hope To Osteoarthritis Patients”

Ed Miseta, Clinical Leader’s Chief Editor, discusses Cynata’s osteoarthritis clinical program and general therapeutic stem cell topics with Cynata’s CEO, Dr Ross Macdonald and COO, Dr Kilian Kelly.

Read entire story